期刊
STEM CELLS TRANSLATIONAL MEDICINE
卷 3, 期 1, 页码 18-31出版社
ALPHAMED PRESS
DOI: 10.5966/sctm.2013-0110
关键词
Cardiac; Embryonic stem cells; Pluripotent stem cells; Differentiation
资金
- NIH [R01 HL093183, HL088434, P20HL100396]
- National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) award [HHSN268201000045C, P50 HL112324]
The generation of human ventricular cardiomyocytes from human embryonic stem cells and/or induced pluripotent stern cells could fulfill the demand for therapeutic applications and in vitro pharmacological research; however, the production of a homogeneous population of ventricular cardiomyocytes remains a major limitation. By combining small molecules and growth factors, we developed a fully chemically defined, directed differentiation system to generate ventricular-like cardiomyocytes (VCMs) from human embryonic stem cells and induced pluripotent stem cells with high efficiency and reproducibility. Molecular characterization revealed that the differentiation recapitulated the developmental steps of cardiovascular fate specification. Electrophysiological analyses further illustrated the generation of a highly enriched population of VCMs. These chemically induced VCMs exhibited the expected cardiac electrophysiological and calcium handling properties as well as the appropriate chronotropic responses to cardioactive compounds. In addition, using an integrated computational and experimental systems biology approach, we demonstrated that the modulation of the canonical Wnt pathway by the small molecule IWR-1 plays a key role in cardiomyocyte subtype specification. In summary, we developed a reproducible and efficient experimental platform that facilitates a chemical genetics-based interrogation of signaling pathways during cardiogenesis that bypasses the limitations of genetic approaches and provides a valuable source of ventricular cardiomyocytes for pharmacological screenings as well as cell replacement therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据